Advanced colorectal adenocarcinoma
Clinical trials for Advanced colorectal adenocarcinoma explained in plain language.
Never miss a new study
Get alerted when new Advanced colorectal adenocarcinoma trials appear
Sign up with your email to follow new studies for Advanced colorectal adenocarcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to outperform standard therapy for advanced colorectal cancer
Disease control Recruiting nowThis phase 3 trial tests whether adding the experimental drug SHR-A1811 to standard chemotherapy and bevacizumab works better than standard therapy alone for people with advanced colorectal cancer who have not had prior treatment. About 300 participants will receive either the ne…
Matched conditions: ADVANCED COLORECTAL ADENOCARCINOMA
Phase 3 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New hope for advanced colon cancer: experimental combo enters phase 2 trial
Disease control Recruiting nowThis study tests a new drug called AMT-676 combined with standard chemotherapy and targeted therapy for people with advanced colorectal cancer that cannot be removed by surgery. The goal is to see if the combination is safe and helps shrink tumors or slow the disease. About 180 a…
Matched conditions: ADVANCED COLORECTAL ADENOCARCINOMA
Phase 2 • Sponsor: Multitude Therapeutics Inc. • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New combo immunotherapy aims to shrink colon tumors before surgery
Disease control Recruiting nowThis study tests whether giving two immunotherapy drugs (botensilimab and balstilimab) before surgery can shrink tumors and improve outcomes for people with advanced colon cancer that can be removed. About 100 adults with stage IIB to IIIC colorectal cancer will receive the drugs…
Matched conditions: ADVANCED COLORECTAL ADENOCARCINOMA
Phase 2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New telehealth program aims to ease daily struggles for advanced cancer patients
Symptom relief Recruiting nowThis study tests a telehealth program called ENGAGE for people with stage IV breast, prostate, lung, or colorectal cancer. The program helps manage symptoms like pain, fatigue, and distress that interfere with daily life. About 190 participants will be randomly assigned to ENGAGE…
Matched conditions: ADVANCED COLORECTAL ADENOCARCINOMA
Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC